Figure 1
From: Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer

Recurrence free survival in patient with percentage of neutrophils lower than 60% (0) and higher than 60% (1).
From: Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer
Recurrence free survival in patient with percentage of neutrophils lower than 60% (0) and higher than 60% (1).